IXICO (FRA:PYPB) Days Payable : 77.63 (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is IXICO Days Payable?

IXICO's average Accounts Payable for the six months ended in Mar. 2024 was €0.76 Mil. IXICO's Cost of Goods Sold for the six months ended in Mar. 2024 was €1.78 Mil. Hence, IXICO's Days Payable for the six months ended in Mar. 2024 was 77.63.

The historical rank and industry rank for IXICO's Days Payable or its related term are showing as below:

FRA:PYPB' s Days Payable Range Over the Past 10 Years
Min: 18.28 Med: 170.05 Max: 269.76
Current: 101.77

During the past 13 years, IXICO's highest Days Payable was 269.76. The lowest was 18.28. And the median was 170.05.

FRA:PYPB's Days Payable is ranked worse than
58.29% of 724 companies
in the Biotechnology industry
Industry Median: 150.695 vs FRA:PYPB: 101.77

IXICO's Days Payable declined from Mar. 2023 (86.08) to Mar. 2024 (77.63). It may suggest that IXICO accelerated paying its suppliers.

IXICO Days Payable Historical Data

The historical data trend for IXICO's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IXICO Days Payable Chart

IXICO Annual Data

Trend

Sep13

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Days Payable

Get a 7-Day Free Trial

250.90

161.88

162.65

53.87

18.12

IXICO Semi-Annual Data
	Mar14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Days Payable	Get a 7-Day Free Trial															124.94	88.14	86.08	78.09	77.63

Competitive Comparison of IXICO's Days Payable

For the Biotechnology subindustry, IXICO's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IXICO's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IXICO's Days Payable distribution charts can be found below:

* The bar in red indicates where IXICO's Days Payable falls into.

IXICO Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

IXICO's Days Payable for the fiscal year that ended in Sep. 2023 is calculated as

	Days Payable (A: Sep. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Sep. 2022 )	+	Accounts Payable (A: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (A: Sep. 2023 )	*	Days in Period
=	( (0.291	+	0.1)	/	2 )	/	3.937	*	365
=	0.1955					/	3.937	*	365
=	18.12

IXICO's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (0.1	+	1.41)	/	2 )	/	1.775	*	365 / 2
=	0.755					/	1.775	*	365 / 2
=	77.63

IXICO Days Payable Related Terms

Thank you for viewing the detailed overview of IXICO's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

IXICO (FRA:PYPB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IXICO PLC (FRA:PYPB) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

PHYOF:USA IXI:UK

Address

15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN

Website

https://www.ixico.com

IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.

IXICO (FRA:PYPB) Headlines

No Headlines